Further investigation of resistance mechanisms has suggested that BRAF-mutated melanoma cells can maintain MAPK signaling through RAF-independent activation of MEK, a kinase downstream of RAF in the MAPK cascade.23 This evidence concerns the gene BRAF and melanoma.